Medical News

RSS

Bruker introduces new NMR-based solution for Aloe Vera quality control at Pittcon 2013

Bruker Corporation introduces Assure – Aloe, an NMR-based solution for Aloe Vera quality control. Fully automated, quantitative and qualitative Nuclear Magnetic Resonance (NMR) analysis enables Aloe vera material screening in the cosmetics, natural products and pharmaceutical industries.

From Bruker BioSpin Division 15 Mar 2016

BD MedMined Surveillance Advisor finishes first in Infection Control and Monitoring category

BD (Becton, Dickinson and Company), a leading medical technology company, announced today that BD MedMined Surveillance Advisor has been named a 2015/2016 Category Leader for Infection Control and Monitoring in the 2015/2016 Best in KLAS: Software and Service report, based on customer feedback.

15 Mar 2016

Bruker showcases innovative NMR solutions for pharmaceutical industry at ENC 2015

At the 56th Experimental Nuclear Magnetic Resonance Conference, Bruker this week is show-casing several innovative drug discovery, drug development and process control solutions for small molecule NMR characterization in the pharmaceutical industry.

From Bruker BioSpin Division 15 Mar 2016

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Orexigen Therapeutics, Inc. today announced Valeant Pharmaceuticals International, Inc. will commercialize Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Central and Eastern Europe.

15 Mar 2016

Study could lead to potential new therapeutic target with fewer side effects for hypertension

A team of Vermont investigators has been issued a patent for their discovery of a molecule that rescues damaged blood vessels, yet preserves healthy vessels and could serve as a springboard for a new pharmaceutical therapy with fewer side effects for hypertension - a major risk factor for cardiovascular and kidney disease that effects roughly one in three people in the U.S.

15 Mar 2016

Learning complex tactile tasks activates the visual cortex

Biology lessons teach us that the brain is divided into separate areas, each of which processes a specific sense. But findings to be published in eLife show we can supercharge it to be more flexible.

15 Mar 2016

Children who receive little to no nutrition during first week in intensive care recover faster

Critically ill children are artificially fed soon after their arrival in intensive care. This common practice is based on the assumption that it will help them recover more quickly. An international study coordinated at KU Leuven, Belgium, has now disproven this theory. The study shows that receiving little to no nutrition during the first week in intensive care makes children recover faster.

15 Mar 2016

Aralez resubmits NDA package for YOSPRALA to FDA

Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company, today announced that it has resubmitted to the U.S. Food and Drug Administration the New Drug Application ("NDA") for its investigational candidate, YOSPRALA (PA32540/PA8140) for the secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ulcers.

15 Mar 2016

Researchers provide new mechanism for age-related macular degeneration

Age-related macular degeneration (AMD) is the leading cause of visual impairment in people over 50 in developed countries. Although this condition affects up to 20% of people between the ages of 65 and 75, what drives abnormal blood vessels to invade the retina is unknown.

15 Mar 2016

Ibrutinib and idelalisib drugs for chronic lymphatic leukaemia can prolong survival time of high-risk patients

Studies conducted at the Comprehensive Cancer Center at MedUni Vienna and Vienna General Hospital show that the drugs ibrutinib and idelalisib used in the targeted treatment of chronic lymphatic leukaemia can significantly prolong the survival time of high-risk patients.

15 Mar 2016

St. Jude scientists develop insights to guide development of powerful novel anti-influenza drugs

By analyzing the molecular details of how artificially created drug-resistant flu strains manage to survive treatment, St. Jude Children's Research Hospital scientists have developed insights to guide development of powerful new anti-influenza drugs. These compounds will target a viral enzyme critical to the virus' proliferation in the body.

15 Mar 2016

UCSF study marks important step toward finding cure for Ebola

In experiments carried out partly at the Department of Energy's SLAC National Accelerator Laboratory, scientists have determined in atomic detail how a potential drug molecule fits into and blocks a channel in cell membranes that Ebola and related "filoviruses" need to infect victims' cells.

15 Mar 2016

Prognostic test could help lower cancer recurrence for colorectal patients

Colorectal cancer, one of the most commonly diagnosed cancers in the United States, is not a commonly discussed disease. Often symptomless in early stages, the cancer is more difficult to treat as it progresses, requiring chemotherapy in later stages. Researchers at the University of Notre Dame are working on a way to identify patients who would benefit from chemotherapy before the cancer progresses.

15 Mar 2016

New blood test may potentially facilitate detection of Alzheimer's disease at early stage

Today, Alzheimer's disease is diagnosed too late. In collaboration with a research team at the university and German Center for Neurogenerative Diseases in Göttingen, Researchers at Ruhr-Universität Bochum have developed a blood test that may potentially facilitate detection of Alzheimer's at an early stage. It is based on an immuno-chemical analysis using an infrared sensor.

15 Mar 2016

New drug shows promise against mesothelioma

A new drug is showing promise as a treatment for mesothelioma - one of the most lethal cancers of all.

15 Mar 2016

Study on kidney cancer can help pave way toward more effective personalized medicine

Understanding the complexity of cancer is a major goal of the scientific community, and for kidney cancer researchers this goal just got closer. Dr. Chad Creighton, associate professor of medicine and member of the Dan L Duncan Comprehensive Cancer Center Division of Biostatistics at Baylor College of Medicine, led the study that analyzed close to 900 kidney cancers at the molecular level.

15 Mar 2016

Humanoid robot can be used as a tool in therapy for improvement of children with autism

Children with autism have special difficulty in expressing emotions, usually have no social skills and face major problems when communicating. In order to help children with this problem learn to recognize facial expressions in themselves and in others, a group of researchers at the Tec de Monterrey, in Mexico, created a robot using artificial intelligence.

15 Mar 2016

HIV drug could delay drug resistance, making skin cancer treatment effective for longer time

An HIV drug could stop one of the early changes in skin cancer cells that leads to them becoming resistant to treatment, according to a Cancer Research UK-funded study published in Cancer Cell today

15 Mar 2016

Heart failure drug has unexpected ability to block herpesvirus infection

Today, there is only one class of antiviral medicines against herpesviruses - a family of viruses that cause mononucleosis, herpes, and shingles, among other illnesses - meaning options for treating these infections are limited. If viruses become resistant to these frontline treatments, a growing problem particularly in clinical settings, there are no alternative drugs to serve as backup.

15 Mar 2016

Researchers identify new mutation responsible for spinocerebellar ataxia

Using the genetic information of two different families with three generations of disease, researchers have identified a new mutation responsible for a degenerative and ultimately fatal movement disorder. Through induced pluripotent stem cell techniques, researchers also grew neurons from one patient in the laboratory to be used in future experiments.

15 Mar 2016

Medical News

Bruker introduces new NMR-based solution for Aloe Vera quality control at Pittcon 2013

BD MedMined Surveillance Advisor finishes first in Infection Control and Monitoring category

Bruker showcases innovative NMR solutions for pharmaceutical industry at ENC 2015

Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba

Study could lead to potential new therapeutic target with fewer side effects for hypertension

Learning complex tactile tasks activates the visual cortex

Children who receive little to no nutrition during first week in intensive care recover faster

Aralez resubmits NDA package for YOSPRALA to FDA

Researchers provide new mechanism for age-related macular degeneration

Ibrutinib and idelalisib drugs for chronic lymphatic leukaemia can prolong survival time of high-risk patients

St. Jude scientists develop insights to guide development of powerful novel anti-influenza drugs

UCSF study marks important step toward finding cure for Ebola

Prognostic test could help lower cancer recurrence for colorectal patients

New blood test may potentially facilitate detection of Alzheimer's disease at early stage

New drug shows promise against mesothelioma

Study on kidney cancer can help pave way toward more effective personalized medicine

Humanoid robot can be used as a tool in therapy for improvement of children with autism

HIV drug could delay drug resistance, making skin cancer treatment effective for longer time

Heart failure drug has unexpected ability to block herpesvirus infection

Researchers identify new mutation responsible for spinocerebellar ataxia

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News